Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 18, 2025
Erratum: Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2025
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 05, 2024
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Journal: Head & neck
Published: July 12, 2016
Showing 1-4 of 4
Last Updated: 09/26/2026